Kuros Biosciences Financials
| CSBTF Stock | USD 22.05 0.55 2.43% |
Kuros |
Understanding current and past Kuros Biosciences Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Kuros Biosciences' financial statements are interrelated, with each one affecting the others. For example, an increase in Kuros Biosciences' assets may result in an increase in income on the income statement.
Kuros Biosciences Stock Summary
Kuros Biosciences competes with Abbott Laboratories, Stryker, Edwards Lifesciences, Boston Scientific, and DexCom. Kuros Biosciences AG, a biopharmaceutical company, engages in the commercialization and development of biopharmaceutical products for tissue repair and bone regeneration in the United States, the European Union, and internationally. It has collaboration with Checkmate Pharmaceuticals LLC for the development of CYT003 for the treatment of oncology. KUROS BIOSCIENCES operates under Biotechnology classification in the United States and is traded on PNK Exchange. It employs 58 people.| Instrument | USA Pink Sheet View All |
| Exchange | PINK Exchange |
| ISIN | CH0325814116 |
| Business Address | Wagistrasse 25, Schlieren, |
| Sector | Healthcare |
| Industry | Biotechnology |
| Benchmark | Dow Jones Industrial |
| Website | www.kuros.ch |
| Phone | 41 44 733 4747 |
| Currency | USD - US Dollar |
Kuros Biosciences Key Financial Ratios
There are many critical financial ratios that Kuros Biosciences' investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Kuros Biosciences reports annually and quarterly.| Return On Equity | -0.14 | |||
| Return On Asset | -0.0667 | |||
| Number Of Employees | 64 | |||
| Beta | 0.77 | |||
| Z Score | 18.6 |
Kuros Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Kuros Biosciences's current stock value. Our valuation model uses many indicators to compare Kuros Biosciences value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Kuros Biosciences competition to find correlations between indicators driving Kuros Biosciences's intrinsic value. More Info.Kuros Biosciences AG is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Kuros Biosciences' earnings, one of the primary drivers of an investment's value.Kuros Biosciences Systematic Risk
Kuros Biosciences' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Kuros Biosciences volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Beta measures systematic risk based on how returns on Kuros Biosciences correlated with the market. If Beta is less than 0 Kuros Biosciences generally moves in the opposite direction as compared to the market. If Kuros Biosciences Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Kuros Biosciences is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Kuros Biosciences is generally in the same direction as the market. If Beta > 1 Kuros Biosciences moves generally in the same direction as, but more than the movement of the benchmark.
Kuros Biosciences March 14, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Kuros Biosciences help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Kuros Biosciences AG. We use our internally-developed statistical techniques to arrive at the intrinsic value of Kuros Biosciences AG based on widely used predictive technical indicators. In general, we focus on analyzing Kuros Pink Sheet price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Kuros Biosciences's daily price indicators and compare them against related drivers.
| Information Ratio | 0.0212 | |||
| Maximum Drawdown | 34.28 | |||
| Value At Risk | (7.94) | |||
| Potential Upside | 7.66 |
Complementary Tools for Kuros Pink Sheet analysis
When running Kuros Biosciences' price analysis, check to measure Kuros Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kuros Biosciences is operating at the current time. Most of Kuros Biosciences' value examination focuses on studying past and present price action to predict the probability of Kuros Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kuros Biosciences' price. Additionally, you may evaluate how the addition of Kuros Biosciences to your portfolios can decrease your overall portfolio volatility.
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Transaction History View history of all your transactions and understand their impact on performance |